Pembrolizumab improves outcomes in high-risk bladder cancer
WEBSep 16, 2024 · NCI Press Office. 240-760-6600. Adjuvant pembrolizumab helps people with muscle-invasive bladder cancer remain cancer-free longer than observation alone. Credit: Terese Winslow/National Cancer Institute. Results from a large clinical trial show that treatment with an immunotherapy drug may nearly …
Major New Drug Approval For Preventing Recurrence In Early …
WEBThe official website for the drug explains, “KISQALI is a targeted treatment for HR+ (ER+ and/or PR+), HER2- metastatic breast cancer that blocks, or interferes with, substances that play a key ...
New lung cancer drug an ‘impressive one-two punch’
WEBLast week, the U.S. Federal Drug Administration approved a therapy involving lazertinib to treat non-small-cell lung cancer patients who have a key gene mutation. The therapy combines lazertinib with another J&J drug, Rybrevant, and reduces the risk of disease progression or death by 30% compared to the current leading chemotherapy-free ...
A newly approved ‘living drug’ could save more cancer patients’ …
WEBAug 22, 2024 · A newly approved ‘living drug’ could save more cancer patients’ lives. Amtagvi, approved for advanced melanoma, is the first T cell therapy for solid tumors. The human immune system produces ...
FDA approves groundbreaking treatment for advanced melanoma - NBC News
WEBFeb 16, 2024 · The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
An experimental cancer drug had a 100% success rate : NPR
WEBJun 7, 2022 · A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment.
Cancer-fighting antibodies inject chemo directly into tumor cells ...
WEBJun 2, 2024 · By attaching a chemotherapy drug to an antibody, doctors are able to deliver more potent cancer-fighting medicines directly into tumor cells, all while causing fewer side effects.
'Cancer-killing pill' that appears to 'annihilate' solid ... - Sky News
WEBAug 2, 2023 · A "cancer-killing pill" has appeared to "annihilate" solid tumours in early research - leaving healthy cells unaffected. The new drug has been in development for 20 years, and is now undergoing pre-clinical research in the US. Known as AOH1996, it targets a cancerous variant of a protein called proliferating cell nuclear antigen (PCNA).
Enhertu Approved for Any HER2-Positive Solid Cancer - NCI
WEBMay 3, 2024 · The drug trastuzumab deruxtecan (Enhertu) can now be used to treat a wide variety of cancers, thanks to a new approval from the Food and Drug Administration (FDA).
Lifileucel First Cellular Therapy Approved for Cancer
WEBMar 5, 2024 · In an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.